Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)
This study has been completed.
Study NCT00093951 Information provided by National Institute on Aging (NIA)
First Received: October 7, 2004 Last Updated: February 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alzheimer's Disease
Additional conditions recognized in this trial
Alzheimer Disease
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies
Interventions listed in this trial
SGS742
Additional drug interventions recognized in this trial
(3-aminopropyl)(n-butyl)phosphinic acid
More general drug interventions related to this trial
Central Nervous System Agents
GABA Agents
GABA Antagonists
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Saegis Pharmaceuticals
Back to top of Main Content
